SpineEX gained additional FDA clearance for the Sagittae Lateral Lumbar Interbody Fusion system, covering new instrumentation and an updated surgical technique.
Bone Biologics received regulatory approval in Australia for a multicenter pilot clinical trial to evaluate NELL-1/DBX® in the treatment of degenerative disc disease.
AlloSource enrolled the first patient in a study to evaluate the effectiveness of ProChondrix CR® fresh cryopreserved osteochondral allograft, when used on cartilage defects in the knee.
Brainlab has acquired Medineering, a developer of application-specific robotic technologies. The move supports Brainlab's growing market reach into ambulatory surgery centers.